Literature DB >> 20540113

TGF-β interactions with IL-1 family members trigger IL-4-independent IL-9 production by mouse CD4(+) T cells.

Catherine Uyttenhove1, Frank Brombacher, Jacques Van Snick.   

Abstract

TGF-β and IL-4 were recently shown to selectively upregulate IL-9 production by naïve CD4(+) T cells. We report here that TGF-β interactions with IL-1α, IL-1β, IL-18, and IL-33 have equivalent IL-9-stimulating activities that function even in IL-4-deficient animals. This was observed after in vitro antigenic stimulation of immunized or unprimed mice and after polyclonal T-cell activation. Based on intracellular IL-9 staining, all IL-9-producing cells were CD4(+) and 80-90% had proliferated, as indicated by reduced CFSE staining. In contrast to IL-9, IL-13 and IL-17 were strongly stimulated by IL-1 and either inhibited (IL-13) or were unaffected (IL-17) by addition of TGF-β. IL-9 and IL-17 production also differed in their dependence on IL-2 and regulation by IL-1/IL-23. As IL-9 levels were much lower in Th2 and Th17 cultures, our results identify TGF-β/IL-1 and TGF-β/IL-4 as the main control points of IL-9 synthesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20540113     DOI: 10.1002/eji.200940281

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  19 in total

Review 1.  The development and in vivo function of T helper 9 cells.

Authors:  Mark H Kaplan; Matthew M Hufford; Matthew R Olson
Journal:  Nat Rev Immunol       Date:  2015-04-07       Impact factor: 53.106

Review 2.  The symphony of the ninth: the development and function of Th9 cells.

Authors:  Rukhsana Jabeen; Mark H Kaplan
Journal:  Curr Opin Immunol       Date:  2012-02-22       Impact factor: 7.486

3.  The many lives of IL-9: a question of survival?

Authors:  Christoph Wilhelm; Jan-Eric Turner; Jacques Van Snick; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2012-06-19       Impact factor: 25.606

Review 4.  Th9 cells in inflammatory bowel diseases.

Authors:  Benno Weigmann; Markus F Neurath
Journal:  Semin Immunopathol       Date:  2016-11-11       Impact factor: 9.623

5.  Amine-reactive OVA multimers for auto-vaccination against cytokines and other mediators: perspectives illustrated for GCP-2 in L. major infection.

Authors:  Catherine Uyttenhove; Reece G Marillier; Fabienne Tacchini-Cottier; Mélanie Charmoy; Rachel R Caspi; Jesse M Damsker; Stanislas Goriely; Dan Su; Jo Van Damme; Sofie Struyf; Ghislain Opdenakker; Jacques Van Snick
Journal:  J Leukoc Biol       Date:  2011-03-08       Impact factor: 4.962

6.  Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity.

Authors:  Christoph Schlapbach; Ahmed Gehad; Chao Yang; Rei Watanabe; Emmanuella Guenova; Jessica E Teague; Laura Campbell; Nikhil Yawalkar; Thomas S Kupper; Rachael A Clark
Journal:  Sci Transl Med       Date:  2014-01-15       Impact factor: 17.956

7.  Profibrotic activities for matrix metalloproteinase-8 during bleomycin-mediated lung injury.

Authors:  Vanessa J Craig; Pablo A Quintero; Susanne E Fyfe; Avignat S Patel; Martin D Knolle; Lester Kobzik; Caroline A Owen
Journal:  J Immunol       Date:  2013-03-13       Impact factor: 5.422

8.  Interleukin-25 (IL-25) promotes efficient protective immunity against Trichinella spiralis infection by enhancing the antigen-specific IL-9 response.

Authors:  Pornpimon Angkasekwinai; Potjanee Srimanote; Yui-Hsi Wang; Anek Pootong; Yuwaporn Sakolvaree; Kovit Pattanapanyasat; Wanpen Chaicumpa; Sansanee Chaiyaroj; Chen Dong
Journal:  Infect Immun       Date:  2013-07-29       Impact factor: 3.441

9.  A gut reaction to IL-9.

Authors:  Matthew M Hufford; Mark H Kaplan
Journal:  Nat Immunol       Date:  2014-07       Impact factor: 25.606

10.  Programmed cell death ligand 2 regulates TH9 differentiation and induction of chronic airway hyperreactivity.

Authors:  Jerome Kerzerho; Hadi Maazi; Anneliese O Speak; Natacha Szely; Vincent Lombardi; Bryant Khoo; Stacey Geryak; Jonathan Lam; Pejman Soroosh; Jacques Van Snick; Omid Akbari
Journal:  J Allergy Clin Immunol       Date:  2012-11-20       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.